Webinar: From Buffer to Plasma: Evaluating Ultra-Sensitive IL-4 ELISA Performance in Human Plasma
Join our supplier Cavidi for a complimentary webinar exploring what happens to ultra-sensitive ELISA performance when you move from buffer into human plasma – using a conjugation-free signal amplification workflow built for biotinylated detection antibodies.
Online
Sensitivity claims established in buffer don't always translate cleanly into plasma. On June 11, Johanna Hedin, Development Engineer at Cavidi, presents spike-and-recovery data from a BOLD-amplified IL-4 sandwich ELISA in human plasma – and introduces a new way to bring Exazym® BOLD amplification directly to any biotinylated detection antibody, with no conjugation step.
What you'll learn:
- IL-4 plasma spike-and-recovery results from a BOLD-amplified sandwich ELISA
- A first look at a new Exazym® reagent that makes BOLD amplification accessible through the biotin–streptavidin interaction
- Live Q&A with Johanna and the Cavidi team
Speaker Spotlight
Johanna Hedin, Development Engineer at Cavidi AB (MSc Infection Biology, Uppsala University), has developed and tested Exazym®-based sandwich ELISAs across multiple biomarkers and sample matrices – including the IL-4 plasma work presented here.
Event Info:
- Date: June 11, 2026
- Time: 16.30 CET
- Duration: 45 minutes
- Format: Live session (limited to 100 participants)
Related images
